While the overwhelming majority of employees and sales come from outside Israel, all but three of 15 board members at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) are Israeli. About half the board has had some experience in the biotech/pharma industry. Six directors have held senior management positions in the industry, two of whom - Chairman Phillip Frost and Arie Belldegrun - have held executive